Search Finnegan

Our Work

1 result

Experience

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Our Insights

34 results

Conference

Life Sciences Patent Network North America Spring Life Sciences Patent Network North America Spring

April 29-30, 2026

Boston

Conference

8th Annual Summit on Life Sciences IP Due Diligence 8th Annual Summit on Life Sciences IP Due Diligence

December 3-4, 2025

Boston

Seminar

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 1, 2025

Cambridge

Conference

2024 Corporate IP Institute 2024 Corporate IP Institute

October 29-30, 2024

Atlanta

Webinar

IP Due Diligence - Everything You Need To Know

IP Due Diligence - Everything You Need To Know IP Due Diligence - Everything You Need To Know

March 30, 2023

Webinar

Conference

The 2nd China Pharma Due Diligence Conference The 2nd China Pharma Due Diligence Conference

September 28-29,2022

Shanghai

Articles

Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech

Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech Top Five Things Cosmetic Companies Need to Know When Adopting AI/AR Tech

October 11, 2021

HAPPI Magazine

Event

IP Risk Management USA 2020 IP Risk Management USA 2020

February 4, 2020

San Jose